Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures
Primary Purpose
Cardiac Surgery
Status
Terminated
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Low Prime
Sponsored by
About this trial
This is an interventional prevention trial for Cardiac Surgery focused on measuring Cardiac surgery, Pump prime, Blood transfusions
Eligibility Criteria
Inclusion Criteria:
- >18 y of age
- Non-emergent complex cardiac surgery (any procedure other than primary isolated CABG)
- Any of the following: Hb < 120 g/L (Females) or < 130 g/L (Males)BSA < 1.6 m2Creatinine Clearance < 60 mL/min (Cockcroft Gault Equation)
Exclusion Criteria:
- aPTT >50 s, INR>1.5
- Plt < 100,000 x 106
- Preoperative Hemodialysis
- Tight aortic stenosis (Aortic Valve Area < 1 cm2)
- Tight lesion of the left main coronary artery (> 60%)
- Use of Aprotinin requested by the Surgical Team
Sites / Locations
Outcomes
Primary Outcome Measures
The number of units of blood products transfused within the first 24 hours post CPB.
Secondary Outcome Measures
Full Information
NCT ID
NCT00646373
First Posted
March 25, 2008
Last Updated
April 19, 2011
Sponsor
University Health Network, Toronto
1. Study Identification
Unique Protocol Identification Number
NCT00646373
Brief Title
Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures
Official Title
Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
December 2006
Overall Recruitment Status
Terminated
Why Stopped
Protocol was comparing to standard of practice, which has changed over the course of slow recruitment and no longer can be used as a comparator.
Study Start Date
December 2006 (undefined)
Primary Completion Date
December 2006 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University Health Network, Toronto
4. Oversight
5. Study Description
Brief Summary
The objective of this study is to evaluate the impact of reduced pump prime on blood transfusions and postoperative complications in patients at high risk of severe hemodilution during CPB.
HYPOTHESIS The use of a new CPB circuit with a smaller internal volume, together with retrograde autologous priming of the lines (RAP) will allow a smaller prime volume and therefore less significant hemodilution on pump.
EXPERIMENTAL DESIGN Overview
Patients will be randomized on the morning of surgery to one of the two study groups in a 1:1 allocation scheme:
Low pump prime
Standard pump prime Outcomes The primary outcome is the number of units of blood products transfused within the first 24 hours post CPB.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Surgery
Keywords
Cardiac surgery, Pump prime, Blood transfusions
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Other
Intervention Name(s)
Low Prime
Intervention Description
The CPB circuit will be primed with mannitol (50 g of 20% solution) and crystalloid solution (Ringer's lactate) for a total volume of approximately 1200 ml.
Primary Outcome Measure Information:
Title
The number of units of blood products transfused within the first 24 hours post CPB.
Time Frame
24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
>18 y of age
Non-emergent complex cardiac surgery (any procedure other than primary isolated CABG)
Any of the following: Hb < 120 g/L (Females) or < 130 g/L (Males)BSA < 1.6 m2Creatinine Clearance < 60 mL/min (Cockcroft Gault Equation)
Exclusion Criteria:
aPTT >50 s, INR>1.5
Plt < 100,000 x 106
Preoperative Hemodialysis
Tight aortic stenosis (Aortic Valve Area < 1 cm2)
Tight lesion of the left main coronary artery (> 60%)
Use of Aprotinin requested by the Surgical Team
12. IPD Sharing Statement
Learn more about this trial
Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures
We'll reach out to this number within 24 hrs